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Introduction
Uterine arteriovenous malformations (AVM) are ex-
tremely rare entities, with less than 100 cases reported in 
the literature. Uterine arteriovenous malformation (AVM) 
is defined as abnormal and nonfunctional connections be-
tween the uterine arteries and veins. The etiology of uterine 
AVM can be congenital or acquired; the incidence rate of 
acquired AVM is currently increasing [1-3]. Congenital le-
sions are considered to occur between the fourth and tenth 
week of embryogenesis as isolated, spontaneous failures of 
vascular development. Acquired malformations are more 
common and usually precede a pregnancy, being diagnosed 
after an uncontrolled uterine bleeding despite drug therapy 
[1]. Synonyms for AVM are arteriovenous fistula, branched 
aneurysm, hemangioma, pulsating angioma, cavernous an-
gioma. AVM consists of proliferation of arterial and venous 
channels with fistula formation and a mixture of capillary-
like vessels. It is difficult to distinguish between arteries and 
veins because secondary intimal thickening occurs in the 
veins due to increased intraluminal pressure [4]. Uterine 
AVM plays an important role in gynecologic practice due to 
the risk of massive bleeding that could be life threatening in 
some patients. In 1926, G. Dubreuil and E. Loubat described 
for the first time this pathology as a “branching aneurysm” 
[5]. Incidence of uterine AVM according to the studies of 
O´Brien et al. [6] who identified uterine AVM in 21 women 
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Abstract
Background: Uterine arteriovenous malformations (AVM) are extremely rare entities, with less than 100 cases reported in the literature. Synonyms for 
AVM are arteriovenous fistula, branched aneurysm, hemangioma, pulsating angioma, and cavernous angioma. Incidence of uterine AVM according to 
the studies of O´Brien et al., who identified uterine AVM in 21 women based on 464 pelvic ultrasound examinations for uterine bleeding, reported an 
incidence of 4.5%. However, Yazawa et al. examined 959 patients prospectively and observed an incidence of 0.6% of uterine vascular malformation on 
ultrasound examination The etiology of uterine AVM can be congenital or acquired. The purpose of the study was to raise awareness on the existence 
of these injuries and understanding their risk factors, to study different treatment methods, especially conservative or minimally invasive ones, as well 
as methods for diagnosing of these malformations. The following key words were used as a search engine: uterine arteriovenous malformation, uterine 
malformation, circoid aneurysm. Only full-text articles were analyzed.
Conclusions: Uterine AVM is a rare cause of uterine bleeding. However, it is a potentially life-threatening disorder in which patients present with vaginal 
bleeding that may be profuse and cause hemodynamic instability.
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based on 464 pelvic ultrasound examinations for uterine 
bleeding, reported an incidence of 4.5%. Instead, Yazawa et 
al. followed up 959 patients prospectively and observed an 
incidence of uterine vascular malformation on ultrasound 
of 0.6% [7]. Some authors consider that the term AVM is 
hyper-used once the number of examinations performed by 
ultrasnography or dopplerography has increased, and the le-
sions detected with hypervascular and/or turbulent flow are 
designated as unfounded “uterine vascular malformations”. 
The term uterine AVM should be limited only to those le-
sions that prove a hypervascular mass, with early filling on 
angiography or on pathological examination of the uterus 
after hysterectomy. Uterine AVM can be the cause of un-
explained uterine bleeding, the severity of which depends 
largely on their occurrence and the diameter of the hemor-
rhagic vessel. Commonly, the only way to stop the bleed-
ing is surgical intervention. The described anomaly repre-
sents a direct communication between arteries and veins, 
formed by the internal iliac artery or its branches. These 
abnormalities consist of dysplastic vessels with an abnor-
mal wall structure and usually persist lifelong, often without 
symptoms. All vascular abnormalities are divided into two 
main types: slow blood flow (capillary, venous, lymphatic) 
and fast blood flow (arteriovenous anastomosis), but some-
times mixed formations are found [8]. Acquired uterine 
arteriovenous abnormalities are most common in patients 
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with trophoblastic disease [9] or previous interventions on 
the uterus, which may be due to a previous uterine trauma 
(prior pelvic operation and curettage), pathologic pregnan-
cy-related conditions and infections [10].  Although there 
are evidences that uterine AVM can be detected in patients 
under 18 years of age [11], usually this pathology is diag-
nosed at the age of over 30 years. According to J. Kasznica 
and N. Nissar arteriovenous abnormalities can also be con-
genital, being  observed in an isolated uterine arteriovenous 
abnormality in a stillborn fetus [12]. Most of the described 
congenital arteriovenous abnormalities were diagnosed by 
ultrasonography in the prenatal and postnatal periods [13]. 
It should be noted that uterine AVMs are extremely rare in 
women who have not been pregnant. Apparently, pregnan-
cy plays a role in the onset of uterine AVM [14]. Often the 
disease is combined with spontaneous abortion. All women 
of reproductive age with abnormal vaginal bleeding and a 
negative pregnancy test (absence of functional trophoblast 
tissue) may be susceptible to uterine AVM [6]. It is impor-
tant to suspect uterine AVM in the differential diagnosis of 
unexplained vaginal bleeding, intermittent births and in 
women of reproductive age, postpartum or following surgi-
cal procedures in the uterus.
Acquired malformations may be due to previous uterine 
trauma (prior pelvic operation and curettage), pathologic 
pregnancy-related conditions, infections, and the treatment 
of gestational trophoblastic disease. Congenital AVMs are 
considered to arise from arrested vascular embryologic 
development resulting in anomalous differentiation in the 
capillaries and abnormal communication, between the ar-
teries and veins. Moreover, congenital AVMs can have mul-
tiple vascular connections and may invade the surrounding 
structures. It is important to diagnose uterine AVM cor-
rectly and to start appropriate treatment promptly, because 
uterine AVM often causes life-threatening massive and per-
sistent vaginal bleeding [15, 16]. 
Although the imaging characteristics of congenital and 
acquired AVMs may be similar, a detailed history may 
help to distinguish between these two. Congenital lesions 
are commonly presented by severe menorrhagia, which do 
not respond to traditional drug therapy. Traumatic uterine 
AVMs are often present with features suggestive of arte-
rial bleeding. They tend to cause episodic vaginal bleeding, 
which is often torrential, leading to significant anemia and 
even shock.
Clinical manifestation
It is important to consider uterine AVMs in the differen-
tial diagnosis of unexplained, intermittent and heavy vagi-
nal bleeding in women of reproductive age, after delivery 
or surgical procedures on the uterus. Although the imaging 
features of congenital and acquired AVMs may be similar, a 
thorough history may help to distinguish between the two 
[6].
Congenital lesions classically present with severe men-
orrhagia, irresponsive to conventional therapy. Acquired or 
traumatic AVMs are invariably associated with one of the 
risk factors previously mentioned. The symptoms can ap-
pear very slowly or suddenly. Vaginal bleeding occurs when 
the endothelial lining of the vessels in the AVM is disrupted, 
such as during menstruation or curettage [17].
Traumatic uterine AVMs often present with features 
suggestive of arterial haemorrhage. They tend to cause epi-
sodic vaginal bleeding, which is often torrential, leading 
to significant anaemia and even shock.  It is critical under 
these circumstances to consider the diagnosis of uterine 
AVM and avoid attempts of uterine instrumentation (dila-
tation and curettage), which may significantly worsen the 
bleeding.  Large AVMs may present as clinically recogniz-
able pulsatile masses, which may aid in making the correct 
diagnosis [18].
Sonographic features suggestive of uterine AVM can be 
found in women, who present with vaginal bleeding and a 
positive pregnancy test. Under these circumstances, preg-
nancy-related conditions, such as intrauterine pregnancy, 
ectopic pregnancy, retained products of conception, or ges-
tational trophoblastic disease should be considered. A com-
bination of history of the specific pattern of vaginal bleed-
ing, a negative pregnancy test and characteristic features 
on colour and spectral Doppler should be used to diagnose 
uterine AVM. 
Investigation
Traditionally, uterine AVMs are diagnosed accidentally 
after hysterectomy based on histopathological evidence of 
arteriovenous fibers. Yet, the gold standard for diagnosing 
uterine AVM is pelvic angiography [15]. Findings with DSA 
include bilateral hypertrophy of uterine arteries that feed a 
tortuous, hypertrophic arterial mass with large accessory 
feeding vessels, and early drainage into enlarged hypertro-
phic veins [19]. However, angiography is rarely performed 
for diagnosis alone, due to its invasive nature and it is usu-
ally reserved when a patient requires surgical intervention 
or embolisation [20]. Gray scale ultrasound (US) can detect 
the presence of multiple tubular or “spongy” anechoic or hy-
poechoic areas within the myometrium of a normal endo-
metrium. However, other conditions may present a similar 
appearance, such as retained products of conception, hem-
angioma, gestational trophoblastic disease, multilocular 
ovarian cysts, or hydrosalpinx. Thus, the use of colour and 
spectral Doppler US is important for obtaining more accu-
rate information. A normal myometrial signal will show a 
PSV of 9–44 cm/s and RI of 0.6–0.8. In addition, uterine 
AVM will exhibit intense vascular and multidirectional flow 
(regions of juxtaposed reds and blues caused by multiple 
tortuous vessels of varying orientations). Spectral Doppler 
US will show high velocity (mean PSV: 136 cm/s), low re-
sistance (mean RI: 0.3) flow, low pulsatility of the arterial 
waveform, and pulsatile high-velocity venous waveform. 
Differentiation between the venous and arterial waveform 
is often difficult, and the pelvic veins distal to the AVM may 
show pulsatile flow instead of the normal monophasic flow 
[15, 21].
Gadolinium-enhanced MRI demonstrates a hypervas-
cular arterial-dominant flow. Similar to MRI, computed 
tomography (CT) may be used to determine the size, ex-
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tent, vascularity, and involvement of the adjacent organs 
[22, 23]. In angiographs, the affected arteries appear thicker 
and more convoluted than the normal ones. AVMs appear 
as a complex tangle of vessels supplied by enlarged feeding 
arteries and show early venous drainage during the arterial 
phase [24]. Angiography, an invasive technique, allows the 
confirmation of the diagnosis and helps identify the lead-
ing feeder vessels where embolization may be indicated as a 
conservative treatment option.
Several cases of AVMs have been found during hysteros-
copy, but their value is limited [25]. Uterine AVMs should 
be differentiated from the retained products of concep-
tion, gestational trophoblastic disease, dysfunctional uter-
ine bleeding, subinvolution, hemangiomas, varicosities, 
and malignancies of the uterus, such as sarcomas. When 
the clinical history, ultrasonographic findings, and serum 
β-hCG test results are considered, AVMs can be differenti-
ated potentially from these pathologic conditions with an 
arteriovenous shunt. Meanwhile, overdiagnosis of uterine 
AVMs should be avoided [22].
Principles of therapeutic management
The therapeutic management of uterine AVM depends 
on the following factors: hemodynamic status, size and lo-
cation of the lesion, degree of hemorrhage, age, desire for 
future fertility. When a woman has severe vaginal bleed-
ing, the basic principles of resuscitation must be followed, 
and stability and hemodynamic recession must be achieved 
and maintained. The mainstay for management of uterine 
AVM has been hysterectomy or the embolization of uterine 
arteries. However, the uterine artery embolization (UAE) 
remains the first choice of treatment in women at reproduc-
tive age having expectation of future fertility [26]. Whether 
this procedure is safe for women desiring future fertility is 
controversial; however, women who become pregnant after 
UAE are at risk of malpresentation, caesarean delivery, pre-
term birth, and postpartum hemorrhage. 
Hysterectomy remains the last but the most appropriate 
treatment, especially for women with uncontrolled bleed-
ing, who do not respond to drug therapy and for people 
who do not want to maintain fertility. Therapeutic options 
for uterine MAVs range from medical hormone therapy to 
uterine artery embolization or permanent hysterectomy. 
Internal iliac artery ligation or uterine artery ligation and/
or hysterectomy were the traditional treatment options for 
counterproductive due to the development of a rich col-
lateral blood supply distal to the ligature, resulting in a re-
currence of hemorrhage after surgery. Advances in pelvic 
angiography and selective arterial embolization techniques 
have shown that embolization is currently the preferred 
therapeutic option for uterine AVM, and internal ligation of 
uterine AVMs in the past, and ligation of the internal iliac 
artery may prove that the iliac artery may have an important 
role in cases of failed embolization. 
A minimally invasive approach through angiographic 
embolization of the AVM is currently the preferred treat-
ment for uterine AVM. There are both permanent and 
temporary methods of embolic agents that can be used as 
an embolic agent. Various embolic materials can be used, 
including polyvinyl alcohol, histoacryl (glue), stainless 
steel coils, detachable balloons, and hemostatic gelatine. 
However, uterine artery embolization may not always be 
successful and multiple sessions may be required for recur-
rent episodes [15]. Imaging assessment of uterine AVMs, 
especially their vascular anatomy, is very important during 
the planning stages before embolization, such as Doppler 
ultrasonography, CT, and MRI [26-29]. Pre-procedural im-
aging evaluation is necessary in order to assess the presence 
of possible extra-uterine feeders. An example is the ovarian-
uterine anastomotic connection, which is often detected 
when performing UAE for uterine fibroids [30, 31]. Possible 
complications of angiographic embolization include infec-
tion, perianal skin sloughing, uterovaginal and rectovagi-
nal fistulas, and neurological deficit in the lower limb [6]. 
Fertility after UAE remains speculative. Despite advances in 
therapeutic techniques and embolic agents, pregnancy fol-
lowing successful embolization of uterine AVMs remains 
rare [32]. Decreased vascularization of the placenta has 
been proposed as being the main cause of adverse pregnan-
cy outcomes following embolization.
 This literature review was made by accessing and ana-
lyzing the MEDLINE and Hinari databases. The key words 
used as search engine were uterine arteriovenous malforma-
tion and uterine malformation. Only full-text articles were 
analyzed. 
Conclusions
Uterine AVM is a rare cause of uterine bleeding. The 
vast majority of AVM cases resolve spontaneously or medi-
cally. The rest of the cases normally respond to conservative 
management options. Uterine AVMs have the potential to 
cause life-threatening bleeding, despite the fact that, with 
the availability of uterine artery embolization, hysterectomy 
is rarely necessary to stop the bleeding. The normal men-
strual cycle and fertility are restored in the vast majority of 
women suffering of this condition.
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